Correlation Between Design Therapeutics and MarksSpencer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and MarksSpencer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and MarksSpencer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and MarksSpencer 7125 percent, you can compare the effects of market volatilities on Design Therapeutics and MarksSpencer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of MarksSpencer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and MarksSpencer.

Diversification Opportunities for Design Therapeutics and MarksSpencer

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Design and MarksSpencer is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and MarksSpencer 7125 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MarksSpencer 7125 percent and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with MarksSpencer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MarksSpencer 7125 percent has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and MarksSpencer go up and down completely randomly.

Pair Corralation between Design Therapeutics and MarksSpencer

Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.44 times more return on investment than MarksSpencer. However, Design Therapeutics is 1.44 times more volatile than MarksSpencer 7125 percent. It trades about 0.0 of its potential returns per unit of risk. MarksSpencer 7125 percent is currently generating about -0.4 per unit of risk. If you would invest  651.00  in Design Therapeutics on October 9, 2024 and sell it today you would lose (20.00) from holding Design Therapeutics or give up 3.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy42.11%
ValuesDaily Returns

Design Therapeutics  vs.  MarksSpencer 7125 percent

 Performance 
       Timeline  
Design Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
MarksSpencer 7125 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MarksSpencer 7125 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for MarksSpencer 7125 percent investors.

Design Therapeutics and MarksSpencer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Design Therapeutics and MarksSpencer

The main advantage of trading using opposite Design Therapeutics and MarksSpencer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, MarksSpencer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MarksSpencer will offset losses from the drop in MarksSpencer's long position.
The idea behind Design Therapeutics and MarksSpencer 7125 percent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
CEOs Directory
Screen CEOs from public companies around the world